Cargando…

Impact of short‐term Dutasteride treatment on prostate‐specific membrane antigen expression in a mouse xenograft model

BACKGROUND: Dutasteride has been shown to increase expression of the prostate‐specific membrane antigen (PSMA) in prostate cancer cells in previous in vitro studies. This 5‐alpha‐reductase inhibitor is commonly used for the treatment of symptomatic benign prostatic enlargement. The modulation of PSM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kranzbühler, Benedikt, Sousa, Rosa, Prause, Lukas, Burger, Irene A., Rupp, Niels J., Sulser, Tullio, Salemi, Souzan, Eberli, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714546/ https://www.ncbi.nlm.nih.gov/pubmed/34008909 http://dx.doi.org/10.1002/cnr2.1418

Ejemplares similares

Improved Prostate-Specific Membrane Antigen (PSMA) Stimulation Using a Super Additive Effect of Dutasteride and Lovastatin In Vitro
por: Kuzmanov, Aleksandar, et al.
Publicado: (2023)

Apalutamide and autophagy inhibition in a xenograft mouse model of human prostate cancer
por: Eberli, Daniel, et al.
Publicado: (2022)

Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death
por: Mortezavi, Ashkan, et al.
Publicado: (2017)

Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with (68)Ga-PSMA-11-PET
por: Ferraro, Daniela A., et al.
Publicado: (2020)

The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride
por: Choi, Yong Hyeuk, et al.
Publicado: (2010)

Injected Human Muscle Precursor Cells Overexpressing PGC-1α Enhance Functional Muscle Regeneration after Trauma
por: Haralampieva, Deana, et al.
Publicado: (2018)

CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors
por: Fankhauser, Christian Daniel, et al.
Publicado: (2019)

Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data
por: Grogg, Josias Bastian, et al.
Publicado: (2020)

The Effect of Finasteride and Dutasteride on the Growth of WPE1-NA22 Prostate Cancer Xenografts in Nude Mice
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2012)

(68)Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer
por: Fassbind, Saskia, et al.
Publicado: (2021)

Tissue Engineering in Pediatric Bladder Reconstruction—The Road to Success
por: Horst, Maya, et al.
Publicado: (2019)

Diagnostic performance of (68)Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study
por: Ferraro, Daniela A., et al.
Publicado: (2021)

Update on the use of dutasteride in the management of benign prostatic hypertrophy
por: Miller, Joe, et al.
Publicado: (2007)

Characteristics of prostate biopsy in patients under the dutasteride treatment
por: Obinata, Daisuke, et al.
Publicado: (2022)

Spheroids of Bladder Smooth Muscle Cells for Bladder Tissue Engineering
por: Gerwinn, Tim, et al.
Publicado: (2021)

Therapy decisions after diagnosis of prostate cancer in men with negative prostate MRI
por: Schmid, Florian A., et al.
Publicado: (2022)

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate
por: Miller, J, et al.
Publicado: (2009)

Response of prostate cancer to addition of dutasteride after progression on abiraterone
por: Lian, Jian-Po, et al.
Publicado: (2020)

Myostatin Overexpression and Smad Pathway in Detrusor Derived from Pediatric Patients with End-Stage Lower Urinary Tract Dysfunction
por: Salemi, Souzan, et al.
Publicado: (2023)

The Effect of Tamsulosin, Dutasteride Monotherapy and Tamsulosin-Dutasteride Combination on Prostate Smooth Muscle Contractility in BPH Model Wistar Strain Rattus Novergicus
por: Daryanto, Besut, et al.
Publicado: (2023)

Autologous transplantation of adipose-derived stem cells improves functional recovery of skeletal muscle without direct participation in new myofiber formation
por: Gorecka, Agata, et al.
Publicado: (2018)

Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
por: Kuiper, Josephina G., et al.
Publicado: (2016)

Adult stem cell sources for skeletal and smooth muscle tissue engineering
por: Salemi, Souzan, et al.
Publicado: (2022)

Short course of dutasteride in treatment of a refractory category IIIB chronic prostatitis (A placebo-controlled study)
por: Higazy, Ahmed, et al.
Publicado: (2022)

Economic Evaluation for Benign Prostatic Hyperplasia in Iran: Surgical Treatment or Dutasteride
por: Khedmati, Jamaleddin, et al.
Publicado: (2021)

Early Dutasteride Monotherapy in Patients With Elevated Serum Prostate-Specific Antigen Levels Following Robot-Assisted Radical Prostatectomy
por: Lu, Chin-Heng, et al.
Publicado: (2019)

Improved oncological outcome after radical prostatectomy in patients staged with (68)Ga-PSMA-11 PET: a single-center retrospective cohort comparison
por: Ferraro, Daniela A., et al.
Publicado: (2020)

Improved contractile potential in detrusor microtissues from pediatric patients with end stage lower urinary tract dysfunction
por: Gerwinn, Tim, et al.
Publicado: (2022)

Scaffold Characteristics for Functional Hollow Organ Regeneration
por: Horst, Maya, et al.
Publicado: (2010)

The Effect of Two Weeks of Treatment with Dutasteride on Bleeding after Transurethral Resection of the Prostate
por: Kim, Kyu Shik, et al.
Publicado: (2015)

Early dutasteride monotherapy in men with detectable serum prostate-specific antigen levels following radical prostatectomy: A prospective trial
por: Shin, Yu Seob, et al.
Publicado: (2017)

Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia
por: Saceda-Corralo, David, et al.
Publicado: (2017)

Dutasteride: an evidence-based review of its clinical impact in the treatment of benign prostatic hyperplasia
por: Thomson, Andrew
Publicado: (2005)

Preparation, Characterization and Stability Study of Dutasteride Loaded Nanoemulsion for Treatment of Benign Prostatic Hypertrophy
por: Ali, Mohammad Sajid, et al.
Publicado: (2014)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Prostate cancer detection rate in men undergoing transperineal template‐guided saturation and targeted prostate biopsy
por: Kaufmann, Basil, et al.
Publicado: (2021)

Does dutasteride reduce perioperative blood loss and postoperative complications after transurethral resection of the prostate?
por: Shanmugasundaram, R., et al.
Publicado: (2007)

Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients
por: Laudicella, Riccardo, et al.
Publicado: (2022)

A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model
por: Udeh, Emeka I., et al.
Publicado: (2016)

Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g01ltclkikb5as6ef8t3menhcd